// App-Quantinova.ai

3346 : Heparin-Induced Thrombocytopenia and Thrombosis: Therapeutic Strategy Using a Single-Chain Variable Fragment (scFv) Antibody

Researchers

Presenter

  • Jose Perdomo

Principal Investigators

  • Xing-Mai Jiang

  • Beng Chong

Medical Centers

  • St George and Sutherland Clinical School, University of New South Wales, Kogarah, Australia

  • Department of Haematology, University of New South Wales & Kogarah, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • Platelet Factor 4

  • Immunoglobulin G

  • L-serine

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved